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The authors have noted that a statement in their Comment incorrectly identified Toxoplasma gondii rather than 
Leishmania as a source of exosomes. The revised sentence appears below. The authors thank Judith Maxwell Silverman, 
PhD, for bringing this error to their attention.
Although most studies have used mammalian cells as the source of exosomes, nonmammalian cells, including pathogenic 
parasites such as Leishmania, can secrete exosomes, and pathogen-derived exosomes may regulate host defense and 
immune responses (Silverman et al., 2010).
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2010. Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. J. Immunol. 
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Published February 18, 2013
The Rockefeller University Press
J. Cell Biol. Vol. 200 No. 4 367–371
www.jcb.org/cgi/doi/10.1083/jcb.201212113 JCB 367
JCB: Comment
30 years ago, a paper in JCB (Harding, Heuser and Stahl, 1983) 
and one in Cell (Pan and Johnstone, 1983)—published within a 
week of each other—reported that, in reticulocytes, transferrin 
receptors associated with small 50 nM vesicles are literally 
jettisoned from maturing blood reticulocytes into the extracel-
lular space. The name “exosome” for these extracellular vesi-
cles was coined a few years later by Rose Johnstone, although 
the term had in fact been used a few years earlier, when refer-
ring to other membrane fragments isolated from biological fluids 
(Trams et al., 1981; the term “exosome complex” has also been 
used for a totally different entity: namely, the intracellular parti-
cle involved in RNA editing [Mitchell et al., 1997]). The promise 
of these early discoveries has been recognized over the inter-
vening three decades by a nearly explosive growth in the field of 
exosome biology, resulting in the formation of various societies 
(International Society for Extracellular Vesicles and The Ameri-
can Society for Exosomes and Microvesicles) and even a dedi-
cated journal (Journal of Extracellular Vesicles), plus numerous 
international meetings and well over a thousand publications on 
exosomes, to date. In this comment, we describe how we dis-
covered this new cellular pathway and provide our perspective 
on the major advances and future directions of this field. For a 
more detailed analysis of the state of the field and its future 
challenges, see Raposo and Stoorvogel (in this issue).
Our investigations were initiated when one of us (C.V. 
Harding), then an MD/PhD student, embarked on a study of en-
docytosis for his PhD thesis and exploited the expertise of two 
adjacent laboratories in the Department of Cell Biology and 
Physiology at Washington University in St. Louis. Work in the 
Stahl laboratory was then focused on defining the pathways of 
receptor-mediated endocytosis and recycling (Stahl et al., 1980) 
Exosomes are extracellular membrane vesicles whose bio-
genesis by exocytosis of multivesicular endosomes was 
discovered in 1983. Since their discovery 30 years ago, 
it has become clear that exosomes contribute to many 
aspects of physiology and disease, including intercellular 
communication. We discuss the initial experiments that 
led to the discovery of exosomes and highlight some of the 
exciting current directions in the field.
Correspondence to Philip D. Stahl: pstahl@wustl.edu
as well as determining the general role of acidic intracellu-
lar compartments in facilitating ligand delivery to lysosomes 
(Tietze et al., 1980). Meanwhile, the Heuser laboratory had re-
cently developed the deep-etch technique for electron micros-
copy (Heuser and Salpeter, 1979) and had already made great 
strides in visualizing synaptic membrane recycling (Heuser et al., 
1979) and the general architecture of endosomes (Heuser, 1980). 
C.V. Harding decided to focus his thesis work on the transferrin 
receptor and to use the reticulocyte or maturing red blood cell 
as a model system because reticulocytes were known to be re-
plete with transferrin receptors. The first paper that grew from 
this three-way collaboration described the recycling of the trans-
ferrin receptor between the plasma membrane and the endocytic 
compartments of the reticulocyte and delineated the role of these 
acidic compartments in iron uptake by reticulocytes (Harding 
and Stahl, 1983). Additional work on the transferrin receptor 
recycling pathway was published around the same time by sev-
eral other groups (Ciechanover et al., 1983; Dautry-Varsat et al., 
1983; Klausner et al., 1983). In retrospect, all of those studies 
(as well as advice from Alan Schwartz and Aaron Ciechanover) 
helped us to begin to grasp the mechanisms of transferrin recy-
cling in reticulocytes.
One well-established fact at that time was that reticulo-
cytes lose the machinery necessary for hemoglobin production 
as they mature into erythrocytes; this includes the loss of the 
machinery necessary for iron transport via transferrin receptors 
(van Bockxmeer and Morgan, 1979). Most people presumed 
that this was simply caused by down-regulation of endocyto-
sis and lysosomal degradation of the transferrin receptors. Our 
thinking about this was suddenly redirected, however, by two 
experiments we did to visualize transferrin receptor turnover by 
monitoring it with colloidal gold-conjugated transferrin (AuTf). 
We found that AuTf particles were indeed internalized by reticu-
locyte transferrin receptors with high fidelity. However, we rarely 
observed any of our gold particles within internal compartments 
in our rat reticulocytes that might be considered lysosomes—on 
the basis of their staining for acid phosphatase or aryl sulfa-
tase—indeed, we found that in general, reticulocytes have pre-
cious few of these sorts of lysosomes (Harding et al., 1983). 
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(which produces vesicles that have subsequently been termed 
“ectosomes” or “microvesicles”). The two simultaneous papers 
nicely complemented each other, as did subsequent papers 
from both groups that provided data to further establish the 
exosome model, e.g., by biochemical purification of exosomes 
and further electron microscopy studies that confirmed the role 
of MVE exocytosis in the genesis of exosomes (Harding et al., 
1984; Pan et al., 1985). Together, these findings developed 
a compelling model for a vesicle and receptor shedding path-
way, though it took some time for appreciation of their gen-
eral significance to extend beyond the reticulocyte/transferrin 
receptor model.
We realized that the MVE–exosome pathway of transfer-
rin receptor shedding was clearly distinct from the pathway for 
recycling of transferrin receptor to the plasma membrane after 
delivery of iron by transferrin. By quantifying the localization 
of intracellular AuTf particles and determining the kinetics of 
transferrin receptor recycling, we generated a model that in-
cluded two pathways for trafficking of internalized transferrin 
receptor in reticulocytes: a fast recycling pathway and a slower 
shedding pathway. Namely, after endocytosis of transferrin re-
ceptors into early endocytic tubules and vesicles, most are rap-
idly recycled to the cell surface, as detected by their rapid 
reappearance and susceptibility to surface trypsinization. How-
ever, the slower second pathway targeted transferrin receptors 
to MVE’s, and the rate of transferrin receptor shedding by this 
pathway matched the rate of transferrin receptor loss from de-
veloping reticulocytes (Harding et al., 1984). This finding im-
plicated the exosome release pathway as the major route for loss 
of transferrin receptor from reticulocytes, a conclusion that fit 
with the findings of Johnstone’s group. Furthermore, in subse-
quent years, it has become apparent that other molecules are 
sorted into vesicles in MVEs for release via the exosome path-
way. The model that appeared in the original JCB paper, further 
detailed in a paper the following year (Fig. 2; Harding et al., 
1984), seems to have withstood the test of time.
Meanwhile, significant progress has been made in de-
veloping an understanding of the cell biology of exosome bio-
genesis. There is agreement that MVEs have two fates in all 
cells—to fuse with the lysosomal compartment where mem-
branes and other content are degraded or to fuse with the plasma 
To our surprise, internalized AuTf particles were located pri-
marily and predominantly on the many small vesicles that we 
observed within multivesicular bodies, and we therefore chose to 
call these organelles multivesicular endosomes (MVEs; Harding 
et al., 1983). We were even more surprised when we observed 
MVEs harboring AuTf-labeled vesicles that appeared to have 
fused with the plasma membrane, as judged by the clear conti-
nuity of their two membranes (Fig. 1, left), and by the obvious 
externalization of their AuTf-labeled vesicles (now known as 
exosomes; Fig. 1, right). To exclude the possibility that these 
results were caused by fixation artifacts, we performed electron 
microscopy on samples that were quick frozen without prior fix-
ation (Fig. 1, right) and observed the same phenomenon. These 
observations revealed a novel mechanism for the loss of trans-
ferrin receptors during maturation of reticulocytes.
This apparent exocytosis of MVEs was a novel and 
interesting finding for many reasons. For one, it countered the 
prevailing view at the time that recycling to the plasma mem-
brane occurred exclusively from early endocytic compartments 
but not from later endocytic compartments, such as MVEs. If 
true, MVE exocytosis could provide a mechanistic explana-
tion for the recycling of internalized molecules that enter much 
more deeply into the endocytic system. The existence of many 
such molecules was subsequently documented: for instance, 
the trafficking of lysosomal LAMP-1 to the plasma membrane 
(Lippincott-Schwartz and Fambrough, 1987) and the traffick-
ing of processed antigens from late endosomes/lysosomes to 
the plasma membrane during class II major histocompatibility 
complex (MHC-II) antigen processing (Harding et al., 1991). 
Even more fundamentally, our first glimpses of MVE exocyto-
sis raised the possibility that cells might use this mechanism as 
a general way to release membrane vesicles, with significance 
far beyond the transferrin receptor system, an idea that has since 
been developed extensively in the exosome field.
Our first images of this MVE externalization event ap-
peared in Harding et al. (1983): an example is shown in Fig. 1. 
At the very same time, Pan and Johnstone (1983) discovered 
that sheep reticulocytes released vesicles of rather uniform size 
that contained transferrin receptor, although they did not directly 
visualize the production of these vesicles and favored a mecha-
nism of vesicle shedding occurring at the plasma membrane 
Figure 1. Exocytosis of MVEs releases exo-
somes containing transferrin receptor. (left) 
View of an MVE from a fixed reticulocyte 
sparsely labeled with AuTf. The apparent fusion 
of the MVE and the plasma membrane may rep-
resent incipient MVE exocytosis. Bar, 100 nm. 
(right) View of MVE exocytosis in a reticulocyte 
labeled with AuTf, quick frozen without prior 
fixation, and freeze substituted. Bar, 200 nm. 
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to T lymphocytes (Ramachandra et al., 2010), although these 
exosomes, like those in some other systems, may be most effec-
tive in antigen presentation when attached to the plasma mem-
brane of cells that display them to T cells (Denzer et al., 2000; 
Théry et al., 2002; Vincent-Schneider et al., 2002). The ability 
of exosomes to directly stimulate naive T cells may be restricted 
to exosomes from dendritic cells provided with a maturation 
stimulus (Segura et al., 2005). The ability of exosomes to stimu-
late T cell responses generated interest in the potential for exo-
somes in immunization, particularly in the tumor immunology 
field, but practical application of exosomes for immunization or 
tumor immunity remains elusive.
In addition to their ability to affect adaptive immunity 
by bearing peptide–MHC complexes or antigen that can be 
processed by antigen-presenting cells for presentation to 
T cells, exosomes may also bear molecules that stimulate innate 
immune responses. Macrophages that are infected with Mtb or 
related mycobacteria produce exosomes containing microbial 
molecules that may signal via innate immune receptors that 
regulate antigen-presenting cells and other cells of the immune 
system (unpublished data; Wearsch, P.A., and J. Athman, per-
sonal communication; Bhatnagar and Schorey, 2007; Bhatnagar 
et al., 2007). Moreover, infection with Mtb (Ramachandra 
et al., 2010) or inflammasome activation (Qu et al., 2007, 
2009) enhances the production of exosomes as well as plasma 
membrane–derived microvesicles. Although most studies have 
used mammalian cells as the source of exosomes, nonmamma-
lian cells, including pathogenic parasites such as Leishmania, 
can secrete exosomes, and pathogen-derived exosomes may 
regulate host defense and immune responses (Silverman et al., 
2010). Thus, exosomes may broadcast signature molecules of 
infection with pathogens, particularly intracellular pathogens, 
allowing one infected cell to influence or recruit many other 
cells, thereby expanding host responses. On the other hand, this 
route may also allow the dissemination of molecules used by 
pathogens to subvert immune responses and promote persis-
tence of infection.
There is currently an explosion of interest in the roles of 
exosomes in intercellular communication. One major aspect 
membrane, resulting in release via the exosome secretion path-
way. MVE formation is now rather well understood, necessary 
components of the endosomal complex required for transport 
(ESCRT) pathway have been identified (Henne et al., 2011), 
and provocative studies on the mechanism of inward vesicle 
budding have been recently published (Hanson et al., 2008; 
Hurley and Hanson, 2010; Henne et al., 2012). Other studies 
have pointed to ceramide and other lipids as mediators of exo-
some biogenesis (Trajkovic et al., 2008). Downstream of MVB 
formation, certain Rab GTPases appear to direct traffic to the 
plasma membrane followed by docking and fusion, opening up 
a range of possibilities for selective regulation. Rab GTPases 
are known to regulate membrane traffic, and initial work (Vidal 
and Stahl, 1993) demonstrated that isolated exosomes are en-
riched in Rab4 and Rab5. Moreover, Savina et al. (2002) impli-
cated Rab11 in exosome secretion, and more recently, Rab27 
and Rab35 have been identified as regulatory GTPases (Hsu 
et al., 2010; Ostrowski et al., 2010). Recent work has dem-
onstrated that elements of the ESCRT pathway, ALIX and 
VPS4, play a role in the secretion of exosomes, especially those 
involved in the trafficking of syndecans (Baietti et al., 2012). 
Lastly, mechanisms that trigger exosome secretion have been 
studied, and calcium transients have been shown to trigger exo-
some secretion, suggesting a tightly regulated process (Savina 
et al., 2005).
Exosomes have become relevant to many fields; we will 
limit this discussion and focus on a few notable topics in immuno-
logy and intercellular communication. In 1996, over a decade 
after the discovery of exosomes in reticulocytes, Raposo et al. 
(1996) demonstrated that MHC-II–enriched MVEs (termed 
“MIIC”) in B lymphocytes fused with the plasma membrane to 
release exosomes bearing MHC-II, and these exosomes were 
able to present peptide–MHC-II complexes to activate T cell 
responses. Soon thereafter, it was shown that dendritic cells 
produce exosomes (Zitvogel et al., 1998; Théry et al., 2001) 
with the capacity to stimulate T cell responses (Théry et al., 
2002). Macrophages also generate exosomes, and macrophages 
infected with Mycobacterium tuberculosis (Mtb) generate exo-
somes that can present Mtb antigen peptide–MHC-II complexes 
Figure 2. Model for routes of transferrin processing in re-
ticulocytes (circa 1983–1984). Transferrin receptors (Tf-R) may 
recycle or be selectively shed from reticulocytes by trafficking 
in the following steps. (a) Diferric transferrin binds surface 
receptors, and receptor–ligand complexes are internalized 
via coated pits and vesicles. (b) Coat loss and fusion events 
produce a pleiomorphic class of small, uncoated vesicles and 
tubules. (c) Iron is removed from transferrin in an acid luminal 
environment and is transferred into the cytoplasm. (d) Apo-
transferrin remains bound to its receptor at acid pH, and both 
receptor and ligand recycle to the plasma membrane, where 
apotransferrin dissociates from the receptor. Alternatively, 
transferrin receptors destined to be shed from the cell segre-
gate on inclusion vesicles of MVEs and are released by MVE 
exocytosis. Model and legend are adapted from Harding 
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of this is the possibility that exosome-associated RNA may be 
delivered to recipient cells, influencing their RNA expression, 
proteome, and functions. These functions could be critical in 
intercellular communication to regulate immune responses or 
many other types of pathophysiological responses. Much ex-
citement was generated with the discovery of both mRNA and 
microRNA in exosomes isolated from mouse and human mast 
cells (Valadi et al., 2007) and the finding that exosomal RNA 
was delivered to target cells, where it was biologically active. 
This discovery opened a new field of inquiry. Initial skepti-
cism that the presence of RNA in exosomes may be incidental 
has now been ruled out by demonstrations showing specific-
ity in exosomal RNA cargo. Exosomes from tumor cells may 
contain RNA that affects other cells to promote tumor pro-
gression (Skog et al., 2008). RNA-bearing exosomes may also 
regulate cells of the immune system, including the interactions 
between antigen-presenting cells and T cells (Mittelbrunn 
et al., 2011). Recent work has demonstrated that the ability 
to produce exosomes in vitro could be exploited to produce a 
“recombinant exosome” that incorporates recognition or homing 
molecules for tissue-specific targeting (Alvarez-Erviti et al., 
2011). This area represents an exciting new area with much 
research activity.
What will the future bring in the field of exosome re-
search? In addition to their importance to fundamental mecha-
nisms of intercellular communication, signaling, and regulation, 
exosomes and other extracellular vesicles may have important 
clinical applications in the future (Raposo and Stoorvogel, 
2013). There is much interest in the potential for diagnostics 
based on analysis of exosomes, as they may bear the protein or 
RNA signatures of pathological or physiological states of their 
source cells. Because exosomes may traffic from tissue sites to 
blood, urine, or other body fluids that are easily accessible, they 
may make such signatures available for diagnostic utilization. 
Furthermore, the potential for RNA-bearing exosomes to influ-
ence or regulate recipient cells suggests the possibility of thera-
peutic applications for cancer, amelioration of pathological 
immune responses (e.g., autoimmunity), and other applications. 
May the next 30 years bring yet more advances!
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